APO Research
Talk to an analyst

APO RESEARCH · REPORT

Malaria Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Malaria Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025197 pages

Choose your research edition.

Industry ResearchMalaria Vaccines Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Malaria Vaccines Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Malaria Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Malaria Vaccines Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Malaria Vaccines Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Malaria Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Malaria Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Malaria Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Malaria Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Malaria Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Malaria Vaccines include Sanofi, Novartis AG, Mylan N.V., Pfizer Inc, GlaxoSmithKline Plc, Zydus Cadila, VLP Therapeutics, Taj Pharmaceuticals Limited and Sun Pharmaceutical Industries Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Malaria Vaccines market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Malaria Vaccines and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Malaria Vaccines revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Malaria Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Malaria Vaccines Segment by Company

Sanofi

Novartis AG

Mylan N.V.

Pfizer Inc

GlaxoSmithKline Plc

Zydus Cadila

VLP Therapeutics

Taj Pharmaceuticals Limited

Sun Pharmaceutical Industries Ltd

Sumaya Biotech

Strides Pharma Science Limited

Sanaria Inc

OSIVAX

Nobelpharma Co

Lupin

Ipca Laboratories Ltd

Hikma Pharmaceuticals PLC

GeoVax

GenVec

Cipla Inc

CellFree Sciences

Bliss GVS Pharma Ltd

Amneal Pharmaceuticals LLC

AJANTA PHARMA

AdvaCare Pharma

Actiza Pharmaceutical Private Limited

Malaria Vaccines Segment by Type

Erythrocytic Vaccine

Pre-Erythrocytic Vaccine

Multi-antigen Vaccine

Malaria Vaccines Segment by Application

Clinics

Hospitals

Community Centers

Malaria Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Malaria Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Malaria Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Malaria Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Malaria Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Malaria Vaccines industry.

Chapter 3: Detailed analysis of Malaria Vaccines companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Malaria Vaccinesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Malaria Vaccines Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Erythrocytic Vaccine Table 3. Key Players of Pre-Erythrocytic Vaccine Table 4. Key Players of Multi-antigen Vaccine Table 4. Global Malaria Vaccines Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Clinics Table 6. Key Players of Hospitals Table 7. Key Players of Community Centers Table 8. Global Malaria Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Malaria Vaccines Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Malaria Vaccines Market Share by Region (2021-2026) Table 11. Global Malaria Vaccines Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Malaria Vaccines Market Share by Region (2027-2032) Table 13. Malaria Vaccines Industry Trends Table 14. Malaria Vaccines Industry Drivers Table 15. Malaria Vaccines Industry Opportunities and Challenges Table 16. Malaria Vaccines Industry Restraints Table 17. Global Malaria Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Malaria Vaccines Revenue Market Share by Company (2021-2026) Table 19. Global Malaria Vaccines Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Malaria Vaccines Key Company Head Office and Area Served Table 21. Global Malaria Vaccines Company, Product Type & Application Table 22. Global Malaria Vaccines Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Malaria Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Malaria Vaccines Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Malaria Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Malaria Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Malaria Vaccines Revenue Market Share by Type (2021-2026) Table 29. Global Malaria Vaccines Revenue Market Share by Type (2027-2032) Table 30. Global Malaria Vaccines Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Malaria Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Malaria Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Malaria Vaccines Revenue Market Share by Application (2021-2026) Table 34. Global Malaria Vaccines Revenue Market Share by Application (2027-2032) Table 35. Sanofi Company Information Table 36. Sanofi Business Overview Table 37. Sanofi Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Sanofi Malaria Vaccines Product Portfolio Table 39. Sanofi Recent Development Table 40. Novartis AG Company Information Table 41. Novartis AG Business Overview Table 42. Novartis AG Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Novartis AG Malaria Vaccines Product Portfolio Table 44. Novartis AG Recent Development Table 45. Mylan N.V. Company Information Table 46. Mylan N.V. Business Overview Table 47. Mylan N.V. Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Mylan N.V. Malaria Vaccines Product Portfolio Table 49. Mylan N.V. Recent Development Table 50. Pfizer Inc Company Information Table 51. Pfizer Inc Business Overview Table 52. Pfizer Inc Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Pfizer Inc Malaria Vaccines Product Portfolio Table 54. Pfizer Inc Recent Development Table 55. GlaxoSmithKline Plc Company Information Table 56. GlaxoSmithKline Plc Business Overview Table 57. GlaxoSmithKline Plc Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. GlaxoSmithKline Plc Malaria Vaccines Product Portfolio Table 59. GlaxoSmithKline Plc Recent Development Table 60. Zydus Cadila Company Information Table 61. Zydus Cadila Business Overview Table 62. Zydus Cadila Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Zydus Cadila Malaria Vaccines Product Portfolio Table 64. Zydus Cadila Recent Development Table 65. VLP Therapeutics Company Information Table 66. VLP Therapeutics Business Overview Table 67. VLP Therapeutics Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. VLP Therapeutics Malaria Vaccines Product Portfolio Table 69. VLP Therapeutics Recent Development Table 70. Taj Pharmaceuticals Limited Company Information Table 71. Taj Pharmaceuticals Limited Business Overview Table 72. Taj Pharmaceuticals Limited Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Taj Pharmaceuticals Limited Malaria Vaccines Product Portfolio Table 74. Taj Pharmaceuticals Limited Recent Development Table 75. Sun Pharmaceutical Industries Ltd Company Information Table 76. Sun Pharmaceutical Industries Ltd Business Overview Table 77. Sun Pharmaceutical Industries Ltd Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Sun Pharmaceutical Industries Ltd Malaria Vaccines Product Portfolio Table 79. Sun Pharmaceutical Industries Ltd Recent Development Table 80. Sumaya Biotech Company Information Table 81. Sumaya Biotech Business Overview Table 82. Sumaya Biotech Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Sumaya Biotech Malaria Vaccines Product Portfolio Table 84. Sumaya Biotech Recent Development Table 85. Strides Pharma Science Limited Company Information Table 86. Strides Pharma Science Limited Business Overview Table 87. Strides Pharma Science Limited Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Strides Pharma Science Limited Malaria Vaccines Product Portfolio Table 89. Strides Pharma Science Limited Recent Development Table 90. Sanaria Inc Company Information Table 91. Sanaria Inc Business Overview Table 92. Sanaria Inc Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Sanaria Inc Malaria Vaccines Product Portfolio Table 94. Sanaria Inc Recent Development Table 95. OSIVAX Company Information Table 96. OSIVAX Business Overview Table 97. OSIVAX Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. OSIVAX Malaria Vaccines Product Portfolio Table 99. OSIVAX Recent Development Table 100. Nobelpharma Co Company Information Table 101. Nobelpharma Co Business Overview Table 102. Nobelpharma Co Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Nobelpharma Co Malaria Vaccines Product Portfolio Table 104. Nobelpharma Co Recent Development Table 105. Lupin Company Information Table 106. Lupin Business Overview Table 107. Lupin Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Lupin Malaria Vaccines Product Portfolio Table 109. Lupin Recent Development Table 110. Ipca Laboratories Ltd Company Information Table 111. Ipca Laboratories Ltd Business Overview Table 112. Ipca Laboratories Ltd Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Ipca Laboratories Ltd Malaria Vaccines Product Portfolio Table 114. Ipca Laboratories Ltd Recent Development Table 115. Hikma Pharmaceuticals PLC Company Information Table 116. Hikma Pharmaceuticals PLC Business Overview Table 117. Hikma Pharmaceuticals PLC Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. Hikma Pharmaceuticals PLC Malaria Vaccines Product Portfolio Table 119. Hikma Pharmaceuticals PLC Recent Development Table 120. GeoVax Company Information Table 121. GeoVax Business Overview Table 122. GeoVax Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. GeoVax Malaria Vaccines Product Portfolio Table 124. GeoVax Recent Development Table 125. GenVec Company Information Table 126. GenVec Business Overview Table 127. GenVec Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 128. GenVec Malaria Vaccines Product Portfolio Table 129. GenVec Recent Development Table 130. Cipla Inc Company Information Table 131. Cipla Inc Business Overview Table 132. Cipla Inc Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 133. Cipla Inc Malaria Vaccines Product Portfolio Table 134. Cipla Inc Recent Development Table 135. CellFree Sciences Company Information Table 136. CellFree Sciences Business Overview Table 137. CellFree Sciences Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 138. CellFree Sciences Malaria Vaccines Product Portfolio Table 139. CellFree Sciences Recent Development Table 140. Bliss GVS Pharma Ltd Company Information Table 141. Bliss GVS Pharma Ltd Business Overview Table 142. Bliss GVS Pharma Ltd Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 143. Bliss GVS Pharma Ltd Malaria Vaccines Product Portfolio Table 144. Bliss GVS Pharma Ltd Recent Development Table 145. Amneal Pharmaceuticals LLC Company Information Table 146. Amneal Pharmaceuticals LLC Business Overview Table 147. Amneal Pharmaceuticals LLC Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 148. Amneal Pharmaceuticals LLC Malaria Vaccines Product Portfolio Table 149. Amneal Pharmaceuticals LLC Recent Development Table 150. AJANTA PHARMA Company Information Table 151. AJANTA PHARMA Business Overview Table 152. AJANTA PHARMA Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 153. AJANTA PHARMA Malaria Vaccines Product Portfolio Table 154. AJANTA PHARMA Recent Development Table 155. AdvaCare Pharma Company Information Table 156. AdvaCare Pharma Business Overview Table 157. AdvaCare Pharma Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 158. AdvaCare Pharma Malaria Vaccines Product Portfolio Table 159. AdvaCare Pharma Recent Development Table 160. Actiza Pharmaceutical Private Limited Company Information Table 161. Actiza Pharmaceutical Private Limited Business Overview Table 162. Actiza Pharmaceutical Private Limited Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 163. Actiza Pharmaceutical Private Limited Malaria Vaccines Product Portfolio Table 164. Actiza Pharmaceutical Private Limited Recent Development Table 165. North America Malaria Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 166. North America Malaria Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 167. North America Malaria Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 168. North America Malaria Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 169. North America Malaria Vaccines Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. North America Malaria Vaccines Market Size by Country (2021-2026) Table 171. North America Malaria Vaccines Market Size by Country (2027-2032) Table 172. Europe Malaria Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 173. Europe Malaria Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 174. Europe Malaria Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 175. Europe Malaria Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 176. Europe Malaria Vaccines Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. Europe Malaria Vaccines Market Size by Country (2021-2026) Table 178. Europe Malaria Vaccines Market Size by Country (2027-2032) Table 179. China Malaria Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 180. China Malaria Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 181. China Malaria Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 182. China Malaria Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 183. Asia Malaria Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 184. Asia Malaria Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 185. Asia Malaria Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 186. Asia Malaria Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 187. Asia Malaria Vaccines Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 188. Asia Malaria Vaccines Market Size by Country (2021-2026) Table 189. Asia Malaria Vaccines Market Size by Country (2027-2032) Table 190. South America, Middle East & Africa Malaria Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 191. South America, Middle East & Africa Malaria Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 192. South America, Middle East & Africa Malaria Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 193. South America, Middle East & Africa Malaria Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 194. South America, Middle East & Africa Malaria Vaccines Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. South America, Middle East & Africa Malaria Vaccines Market Size by Country (2021-2026) Table 196. South America, Middle East & Africa Malaria Vaccines Market Size by Country (2027-2032) Table 197. Research Programs/Design for This Report Table 198. Authors List of This Report Table 199. Secondary Sources Table 200. Primary Sources List of Figures Figure 1. Malaria Vaccines Product Image Figure 2. Global Malaria Vaccines Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Malaria Vaccines Market Share by Type: 2025 VS 2032 Figure 4. Erythrocytic Vaccine Image Figure 5. Pre-Erythrocytic Vaccine Image Figure 6. Multi-antigen Vaccine Image Figure 7. Global Malaria Vaccines Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Malaria Vaccines Market Share by Application: 2025 VS 2032 Figure 9. Clinics Image Figure 10. Hospitals Image Figure 11. Community Centers Image Figure 12. Global Malaria Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 14. Global Malaria Vaccines Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Malaria Vaccines Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Malaria Vaccines Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Malaria Vaccines Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Malaria Vaccines Revenue Market Share by Type (2021-2032) Figure 21. Global Malaria Vaccines Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Malaria Vaccines Revenue Market Share by Application (2021-2032) Figure 23. North America Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 24. North America Malaria Vaccines Market Share by Type (2021-2032) Figure 25. North America Malaria Vaccines Market Share by Application (2021-2032) Figure 26. North America Malaria Vaccines Market Share by Country (2021-2032) Figure 27. United States Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 28. Canada Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 30. Europe Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 31. Europe Malaria Vaccines Market Share by Type (2021-2032) Figure 32. Europe Malaria Vaccines Market Share by Application (2021-2032) Figure 33. Europe Malaria Vaccines Market Share by Country (2021-2032) Figure 34. Germany Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 35. France Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 37. Italy Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 38. Russia Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 40. China Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 41. China Malaria Vaccines Market Share by Type (2021-2032) Figure 42. China Malaria Vaccines Market Share by Application (2021-2032) Figure 43. Asia Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 44. Asia Malaria Vaccines Market Share by Type (2021-2032) Figure 45. Asia Malaria Vaccines Market Share by Application (2021-2032) Figure 46. Asia Malaria Vaccines Market Share by Country (2021-2032) Figure 47. Japan Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 51. India Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 52. Australia Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Malaria Vaccines Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Malaria Vaccines Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Malaria Vaccines Market Share by Country (2021-2032) Figure 57. Brazil Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 62. UAE Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 64. Chile Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Erythrocytic Vaccine
  • Pre-Erythrocytic Vaccine
  • Multi-antigen Vaccine
Applications
  • Clinics
  • Hospitals
  • Community Centers
Companies covered
  • Sanofi
  • Novartis AG
  • Mylan N.V.
  • Pfizer Inc
  • GlaxoSmithKline Plc
  • Zydus Cadila
  • VLP Therapeutics
  • Taj Pharmaceuticals Limited
  • Sun Pharmaceutical Industries Ltd
  • Sumaya Biotech
  • Strides Pharma Science Limited
  • Sanaria Inc
  • OSIVAX
  • Nobelpharma Co
  • Lupin
  • Ipca Laboratories Ltd
  • Hikma Pharmaceuticals PLC
  • GeoVax
  • GenVec
  • Cipla Inc
  • CellFree Sciences
  • Bliss GVS Pharma Ltd
  • Amneal Pharmaceuticals LLC
  • AJANTA PHARMA
  • AdvaCare Pharma
  • Actiza Pharmaceutical Private Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Malaria Vaccines Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Erythrocytic Vaccine
  5. 1.2.3 Pre-Erythrocytic Vaccine
  6. 1.2.4 Multi-antigen Vaccine
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Malaria Vaccines Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Clinics
  10. 1.3.3 Hospitals
  11. 1.3.4 Community Centers
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Malaria Vaccines Growth Trends by Region
  14. 1.5.1 Global Malaria Vaccines Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Malaria Vaccines Market Size by Region (2021-2026)
  16. 1.5.3 Malaria Vaccines Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Malaria Vaccines Market Dynamics
  1. 2.1 Malaria Vaccines Industry Trends
  2. 2.2 Malaria Vaccines Industry Drivers
  3. 2.3 Malaria Vaccines Industry Opportunities and Challenges
  4. 2.4 Malaria Vaccines Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Malaria Vaccines Revenue by Company (2021-2026)
  2. 3.2 Global Malaria Vaccines Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Malaria Vaccines Key Company Head office and Area Served
  4. 3.4 Global Malaria Vaccines Company, Product Type & Application
  5. 3.5 Global Malaria Vaccines Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Malaria Vaccines Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Malaria Vaccines Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Malaria Vaccines Tier 1, Tier 2, and Tier 3
4 Malaria Vaccines Market by Type
  1. 4.1 Global Malaria Vaccines Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Malaria Vaccines Market Size by Type (2021-2032)
  3. 4.3 Global Malaria Vaccines Market Size Share by Type (2021-2032)
5 Malaria Vaccines Market by Application
  1. 5.1 Global Malaria Vaccines Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Malaria Vaccines Market Size by Application (2021-2032)
  3. 5.3 Global Malaria Vaccines Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Sanofi Malaria Vaccines Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Novartis AG
  8. 6.2.1 Novartis AG Company Information
  9. 6.2.2 Novartis AG Business Overview
  10. 6.2.3 Novartis AG Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Novartis AG Malaria Vaccines Product Portfolio
  12. 6.2.5 Novartis AG Recent Developments
  13. 6.3 Mylan N.V.
  14. 6.3.1 Mylan N.V. Company Information
  15. 6.3.2 Mylan N.V. Business Overview
  16. 6.3.3 Mylan N.V. Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Mylan N.V. Malaria Vaccines Product Portfolio
  18. 6.3.5 Mylan N.V. Recent Developments
  19. 6.4 Pfizer Inc
  20. 6.4.1 Pfizer Inc Company Information
  21. 6.4.2 Pfizer Inc Business Overview
  22. 6.4.3 Pfizer Inc Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Pfizer Inc Malaria Vaccines Product Portfolio
  24. 6.4.5 Pfizer Inc Recent Developments
  25. 6.5 GlaxoSmithKline Plc
  26. 6.5.1 GlaxoSmithKline Plc Company Information
  27. 6.5.2 GlaxoSmithKline Plc Business Overview
  28. 6.5.3 GlaxoSmithKline Plc Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 GlaxoSmithKline Plc Malaria Vaccines Product Portfolio
  30. 6.5.5 GlaxoSmithKline Plc Recent Developments
  31. 6.6 Zydus Cadila
  32. 6.6.1 Zydus Cadila Company Information
  33. 6.6.2 Zydus Cadila Business Overview
  34. 6.6.3 Zydus Cadila Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Zydus Cadila Malaria Vaccines Product Portfolio
  36. 6.6.5 Zydus Cadila Recent Developments
  37. 6.7 VLP Therapeutics
  38. 6.7.1 VLP Therapeutics Company Information
  39. 6.7.2 VLP Therapeutics Business Overview
  40. 6.7.3 VLP Therapeutics Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 VLP Therapeutics Malaria Vaccines Product Portfolio
  42. 6.7.5 VLP Therapeutics Recent Developments
  43. 6.8 Taj Pharmaceuticals Limited
  44. 6.8.1 Taj Pharmaceuticals Limited Company Information
  45. 6.8.2 Taj Pharmaceuticals Limited Business Overview
  46. 6.8.3 Taj Pharmaceuticals Limited Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Taj Pharmaceuticals Limited Malaria Vaccines Product Portfolio
  48. 6.8.5 Taj Pharmaceuticals Limited Recent Developments
  49. 6.9 Sun Pharmaceutical Industries Ltd
  50. 6.9.1 Sun Pharmaceutical Industries Ltd Company Information
  51. 6.9.2 Sun Pharmaceutical Industries Ltd Business Overview
  52. 6.9.3 Sun Pharmaceutical Industries Ltd Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Sun Pharmaceutical Industries Ltd Malaria Vaccines Product Portfolio
  54. 6.9.5 Sun Pharmaceutical Industries Ltd Recent Developments
  55. 6.10 Sumaya Biotech
  56. 6.10.1 Sumaya Biotech Company Information
  57. 6.10.2 Sumaya Biotech Business Overview
  58. 6.10.3 Sumaya Biotech Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Sumaya Biotech Malaria Vaccines Product Portfolio
  60. 6.10.5 Sumaya Biotech Recent Developments
  61. 6.11 Strides Pharma Science Limited
  62. 6.11.1 Strides Pharma Science Limited Company Information
  63. 6.11.2 Strides Pharma Science Limited Business Overview
  64. 6.11.3 Strides Pharma Science Limited Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Strides Pharma Science Limited Malaria Vaccines Product Portfolio
  66. 6.11.5 Strides Pharma Science Limited Recent Developments
  67. 6.12 Sanaria Inc
  68. 6.12.1 Sanaria Inc Company Information
  69. 6.12.2 Sanaria Inc Business Overview
  70. 6.12.3 Sanaria Inc Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Sanaria Inc Malaria Vaccines Product Portfolio
  72. 6.12.5 Sanaria Inc Recent Developments
  73. 6.13 OSIVAX
  74. 6.13.1 OSIVAX Company Information
  75. 6.13.2 OSIVAX Business Overview
  76. 6.13.3 OSIVAX Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 OSIVAX Malaria Vaccines Product Portfolio
  78. 6.13.5 OSIVAX Recent Developments
  79. 6.14 Nobelpharma Co
  80. 6.14.1 Nobelpharma Co Company Information
  81. 6.14.2 Nobelpharma Co Business Overview
  82. 6.14.3 Nobelpharma Co Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Nobelpharma Co Malaria Vaccines Product Portfolio
  84. 6.14.5 Nobelpharma Co Recent Developments
  85. 6.15 Lupin
  86. 6.15.1 Lupin Company Information
  87. 6.15.2 Lupin Business Overview
  88. 6.15.3 Lupin Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Lupin Malaria Vaccines Product Portfolio
  90. 6.15.5 Lupin Recent Developments
  91. 6.16 Ipca Laboratories Ltd
  92. 6.16.1 Ipca Laboratories Ltd Company Information
  93. 6.16.2 Ipca Laboratories Ltd Business Overview
  94. 6.16.3 Ipca Laboratories Ltd Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Ipca Laboratories Ltd Malaria Vaccines Product Portfolio
  96. 6.16.5 Ipca Laboratories Ltd Recent Developments
  97. 6.17 Hikma Pharmaceuticals PLC
  98. 6.17.1 Hikma Pharmaceuticals PLC Company Information
  99. 6.17.2 Hikma Pharmaceuticals PLC Business Overview
  100. 6.17.3 Hikma Pharmaceuticals PLC Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Hikma Pharmaceuticals PLC Malaria Vaccines Product Portfolio
  102. 6.17.5 Hikma Pharmaceuticals PLC Recent Developments
  103. 6.18 GeoVax
  104. 6.18.1 GeoVax Company Information
  105. 6.18.2 GeoVax Business Overview
  106. 6.18.3 GeoVax Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 GeoVax Malaria Vaccines Product Portfolio
  108. 6.18.5 GeoVax Recent Developments
  109. 6.19 GenVec
  110. 6.19.1 GenVec Company Information
  111. 6.19.2 GenVec Business Overview
  112. 6.19.3 GenVec Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 GenVec Malaria Vaccines Product Portfolio
  114. 6.19.5 GenVec Recent Developments
  115. 6.20 Cipla Inc
  116. 6.20.1 Cipla Inc Company Information
  117. 6.20.2 Cipla Inc Business Overview
  118. 6.20.3 Cipla Inc Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Cipla Inc Malaria Vaccines Product Portfolio
  120. 6.20.5 Cipla Inc Recent Developments
  121. 6.21 CellFree Sciences
  122. 6.21.1 CellFree Sciences Company Information
  123. 6.21.2 CellFree Sciences Business Overview
  124. 6.21.3 CellFree Sciences Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 CellFree Sciences Malaria Vaccines Product Portfolio
  126. 6.21.5 CellFree Sciences Recent Developments
  127. 6.22 Bliss GVS Pharma Ltd
  128. 6.22.1 Bliss GVS Pharma Ltd Company Information
  129. 6.22.2 Bliss GVS Pharma Ltd Business Overview
  130. 6.22.3 Bliss GVS Pharma Ltd Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  131. 6.22.4 Bliss GVS Pharma Ltd Malaria Vaccines Product Portfolio
  132. 6.22.5 Bliss GVS Pharma Ltd Recent Developments
  133. 6.23 Amneal Pharmaceuticals LLC
  134. 6.23.1 Amneal Pharmaceuticals LLC Company Information
  135. 6.23.2 Amneal Pharmaceuticals LLC Business Overview
  136. 6.23.3 Amneal Pharmaceuticals LLC Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  137. 6.23.4 Amneal Pharmaceuticals LLC Malaria Vaccines Product Portfolio
  138. 6.23.5 Amneal Pharmaceuticals LLC Recent Developments
  139. 6.24 AJANTA PHARMA
  140. 6.24.1 AJANTA PHARMA Company Information
  141. 6.24.2 AJANTA PHARMA Business Overview
  142. 6.24.3 AJANTA PHARMA Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  143. 6.24.4 AJANTA PHARMA Malaria Vaccines Product Portfolio
  144. 6.24.5 AJANTA PHARMA Recent Developments
  145. 6.25 AdvaCare Pharma
  146. 6.25.1 AdvaCare Pharma Company Information
  147. 6.25.2 AdvaCare Pharma Business Overview
  148. 6.25.3 AdvaCare Pharma Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  149. 6.25.4 AdvaCare Pharma Malaria Vaccines Product Portfolio
  150. 6.25.5 AdvaCare Pharma Recent Developments
  151. 6.26 Actiza Pharmaceutical Private Limited
  152. 6.26.1 Actiza Pharmaceutical Private Limited Company Information
  153. 6.26.2 Actiza Pharmaceutical Private Limited Business Overview
  154. 6.26.3 Actiza Pharmaceutical Private Limited Malaria Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  155. 6.26.4 Actiza Pharmaceutical Private Limited Malaria Vaccines Product Portfolio
  156. 6.26.5 Actiza Pharmaceutical Private Limited Recent Developments
7 North America
  1. 7.1 North America Malaria Vaccines Market Size (2021-2032)
  2. 7.2 North America Malaria Vaccines Market Size by Type
  3. 7.2.1 North America Malaria Vaccines Market Size by Type (2021-2026)
  4. 7.2.2 North America Malaria Vaccines Market Size by Type (2027-2032)
  5. 7.2.3 North America Malaria Vaccines Market Share by Type (2021-2032)
  6. 7.3 North America Malaria Vaccines Market Size by Application
  7. 7.3.1 North America Malaria Vaccines Market Size by Application (2021-2026)
  8. 7.3.2 North America Malaria Vaccines Market Size by Application (2027-2032)
  9. 7.3.3 North America Malaria Vaccines Market Share by Application (2021-2032)
  10. 7.4 North America Malaria Vaccines Market Size by Country
  11. 7.4.1 North America Malaria Vaccines Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Malaria Vaccines Market Size by Country (2021-2026)
  13. 7.4.3 North America Malaria Vaccines Market Size by Country (2027-2032)
  14. 7.4.4 North America Malaria Vaccines Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Malaria Vaccines Market Size (2021-2032)
  2. 8.2 Europe Malaria Vaccines Market Size by Type
  3. 8.2.1 Europe Malaria Vaccines Market Size by Type (2021-2026)
  4. 8.2.2 Europe Malaria Vaccines Market Size by Type (2027-2032)
  5. 8.2.3 Europe Malaria Vaccines Market Share by Type (2021-2032)
  6. 8.3 Europe Malaria Vaccines Market Size by Application
  7. 8.3.1 Europe Malaria Vaccines Market Size by Application (2021-2026)
  8. 8.3.2 Europe Malaria Vaccines Market Size by Application (2027-2032)
  9. 8.3.3 Europe Malaria Vaccines Market Share by Application (2021-2032)
  10. 8.4 Europe Malaria Vaccines Market Size by Country
  11. 8.4.1 Europe Malaria Vaccines Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Malaria Vaccines Market Size by Country (2021-2026)
  13. 8.4.3 Europe Malaria Vaccines Market Size by Country (2027-2032)
  14. 8.4.4 Europe Malaria Vaccines Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Malaria Vaccines Market Size (2021-2032)
  2. 9.2 China Malaria Vaccines Market Size by Type
  3. 9.2.1 China Malaria Vaccines Market Size by Type (2021-2026)
  4. 9.2.2 China Malaria Vaccines Market Size by Type (2027-2032)
  5. 9.2.3 China Malaria Vaccines Market Share by Type (2021-2032)
  6. 9.3 China Malaria Vaccines Market Size by Application
  7. 9.3.1 China Malaria Vaccines Market Size by Application (2021-2026)
  8. 9.3.2 China Malaria Vaccines Market Size by Application (2027-2032)
  9. 9.3.3 China Malaria Vaccines Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Malaria Vaccines Market Size (2021-2032)
  2. 10.2 Asia Malaria Vaccines Market Size by Type
  3. 10.2.1 Asia Malaria Vaccines Market Size by Type (2021-2026)
  4. 10.2.2 Asia Malaria Vaccines Market Size by Type (2027-2032)
  5. 10.2.3 Asia Malaria Vaccines Market Share by Type (2021-2032)
  6. 10.3 Asia Malaria Vaccines Market Size by Application
  7. 10.3.1 Asia Malaria Vaccines Market Size by Application (2021-2026)
  8. 10.3.2 Asia Malaria Vaccines Market Size by Application (2027-2032)
  9. 10.3.3 Asia Malaria Vaccines Market Share by Application (2021-2032)
  10. 10.4 Asia Malaria Vaccines Market Size by Country
  11. 10.4.1 Asia Malaria Vaccines Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Malaria Vaccines Market Size by Country (2021-2026)
  13. 10.4.3 Asia Malaria Vaccines Market Size by Country (2027-2032)
  14. 10.4.4 Asia Malaria Vaccines Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Malaria Vaccines Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Malaria Vaccines Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Malaria Vaccines Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Malaria Vaccines Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Malaria Vaccines Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Malaria Vaccines Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Malaria Vaccines Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Malaria Vaccines Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Malaria Vaccines Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Malaria Vaccines Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Malaria Vaccines Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Malaria Vaccines Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Malaria Vaccines Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Malaria Vaccines Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst